Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Nutrients ; 13(10)2021 Oct 19.
Article in English | MEDLINE | ID: mdl-34684653

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) shows extensive liver cell destruction with lipid accumulation, which is frequently accompanied by metabolic comorbidities and increases mortality. This study aimed to investigate the effects of coffeeberry (CB) on regulating the redox status, the CaMKII/CREB/BDNF pathway, autophagy, and apoptosis signaling by a NAFLD rodent model senescence-accelerated mice prone 8 (SAMP8). Three-month-old male SAMP8 mice were divided into a control group and three CB groups (50, 100, and 200 mg/kg BW), and fed for 12 weeks. The results show that CB reduced hepatic malondialdehyde and carbonyl protein levels. CB significantly enhanced Ca2+/calmodulin-dependent protein kinase II (CaMKII) and brain-derived neurotrophic factor (BDNF) and reduced the phospho-cAMP response element-binding protein (p-CREB)/CREB ratio. In addition, CB increased the silent information regulator T1 level, promoted Beclin 1 and microtubule-associated protein light chain 3 II expressions, and reduced phosphorylated mammalian target of rapamycin and its downstream p-p70s6k levels. CB also inhibited the expressions of apoptosis-related factors poly (ADP-ribose) polymerase-1 and the apoptosis-inducing factor. In conclusion, CB might protect the liver by reducing oxidative stress, activating the CaMKII/CREB/BDNF pathway, and improving autophagic and apoptotic expressions in a dose-dependent manner.


Subject(s)
Apoptosis , Autophagy , Brain-Derived Neurotrophic Factor/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Coffee/chemistry , Cyclic AMP Response Element-Binding Protein/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Signal Transduction , Animals , Caspases/metabolism , Feeding Behavior , Liver/pathology , Male , Malondialdehyde/metabolism , Mice , Non-alcoholic Fatty Liver Disease/pathology , Organ Size , Oxidation-Reduction , Protein Carbonylation , Weight Gain
2.
Cancer Immunol Immunother ; 60(7): 1019-27, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21499904

ABSTRACT

DNA vaccine has been suggested to use in cancer therapy, but the efficacy remains to be improved. The immunostimulatory effect of a fungal immunomodulatory protein Ling Zhi-8 (LZ-8) isolated from Ganoderma lucidum has been reported. In this study, we tested the adjuvanticity of LZ-8 for HER-2/neu DNA vaccine against p185(neu) expressing tumor MBT-2 in mice. We found that recombinant LZ-8 stimulated mouse bone marrow-derived dendritic cells (DCs) via TLR4 and its stimulatory effect was not due to any microbe contaminant. In addition, LZ-8 enhanced the ability of DCs to induce antigen-specific T cell activation in vitro and in a subunit vaccine model in vivo. Surprisingly, LZ-8 cotreatment strongly improved the therapeutic effect of DNA vaccine against MBT-2 tumor in mice. This increase in antitumor activity was attributed to the enhancement of vaccine-induced Th1 and CTL responses. Consistent with the results from DCs, the promoting effect of LZ-8 on DNA vaccine was diminished when the MBT-2 tumor cells were grown in TLR4 mutant mice. Thus, we concluded that LZ-8 may be a promising adjuvant to enhance the efficacy of DNA vaccine by activating DCs via TLR4.


Subject(s)
Cancer Vaccines/therapeutic use , Dendritic Cells/immunology , Fungal Proteins/immunology , Urinary Bladder Neoplasms/therapy , Vaccines, DNA/therapeutic use , Adjuvants, Immunologic , Animals , Blotting, Western , Disease Models, Animal , Fungal Proteins/genetics , Lymphocyte Activation , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , RNA, Messenger/genetics , Receptor, ErbB-2/genetics , Receptor, ErbB-2/immunology , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes, Cytotoxic/immunology , Transduction, Genetic , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/immunology
SELECTION OF CITATIONS
SEARCH DETAIL